Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Operating Leases (2019 - 2025)

Perspective Therapeutics' Operating Leases history spans 7 years, with the latest figure at $971000.0 for Q3 2025.

  • For Q3 2025, Operating Leases fell 42.06% year-over-year to $971000.0; the TTM value through Sep 2025 reached $971000.0, down 42.06%, while the annual FY2024 figure was $1.4 million, 83.08% up from the prior year.
  • Operating Leases for Q3 2025 was $971000.0 at Perspective Therapeutics, down from $1.1 million in the prior quarter.
  • Across five years, Operating Leases topped out at $1.7 million in Q3 2024 and bottomed at $186000.0 in Q3 2022.
  • The 5-year median for Operating Leases is $809000.0 (2021), against an average of $831388.9.
  • The largest annual shift saw Operating Leases crashed 73.99% in 2022 before it surged 586.02% in 2023.
  • A 5-year view of Operating Leases shows it stood at $392000.0 in 2021, then crashed by 52.55% to $186000.0 in 2022, then soared by 319.35% to $780000.0 in 2023, then soared by 83.08% to $1.4 million in 2024, then crashed by 32.0% to $971000.0 in 2025.
  • Per Business Quant, the three most recent readings for CATX's Operating Leases are $971000.0 (Q3 2025), $1.1 million (Q2 2025), and $1.2 million (Q1 2025).